To determine the mean change in serum vitamin D levels in vitiligo patients undergoing NBUVB phototherapy
DOI:
https://doi.org/10.66344/jpad.29.1.2019.1350Keywords:
Vitiligo, Serum vitamin D levels, Narrowband Ultraviolet B phototherapyAbstract
Background Vitiligo is a common, acquired, often heritable, multifactorial pigmentary disorder with a complex pathogenesis. Vitamin D is a fat soluble essential hormone synthesized in the skin on exposure to ultraviolet B present in the sunlight. It plays its role in calcium homeostasis as well as in immunoregulation. Low levels of vitamin D have been observed in vitiligo patients, who seem to improve with NBUVB treatment. Objective To determine the mean change in serum vitamin D levels in patients of vitiligo after narrow band ultraviolet B therapy. Study design Quasi experimental. Settings Dermatology Department, Pakistan Air Force Hospital, E9, Islamabad. Duration of study Study was carried out over a period of six months from 10-05-2017 to 09-11-2017. Subjects and Methods A total of 30 patients were included in this study. Serum vitamin D level was analyzed at baseline in all the patients who planned to undergo Narrow Band Ultraviolet B phototherapy for vitiligo. The phototherapy was given for 8 weeks and vitamin D levels were measured again. Results Mean age of the patients was 32.77±10.68 years. There were 18 males (60%) and 12 females (40%). Pre-treatment serum vitamin D levels were 25.97±16.10 nmol/l while post-treatment serum vitamin D levels were 39.07±15.67 nmol/l (p<0.001). Conclusion In conclusion, low vitamin D levels in vitiligo patients were improved after narrow band ultraviolet B phototherapy, which may contribute to its therapeutic efficacy.ÂReferences
Boone B, Ongenae K, Geel NV et al. Topical pimecrolimus in the treatment of vitiligo. Eur J Dermatol 2006; 17 (1): 1-7
Farajzadeh S, Aflatoonian M, Mohammadi S, Vares B, Amiri R. Epidemiological aspects and disease association of childhood vitiligo. J Pak Assoc Derma 2015; 15:105-10.
Habib A, Raza N. Clinical Pattern of Vitiligo. J Coll Physicians Surg Pak 2012; 22:61-2.
Le Poole IC, Luiten RM. Autoimmune etiology of generalized vitiligo. Curr Dir Autoimmun 2008; 10: 227-43.
Ongenae K, Dierckxsens L, Brochez L. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage. Dermatology 2005; 210: 279–85.
Whitton ME, Ashcroft DM, Barrett CW, Gonzalez U. Interventions for vitiligo. Cochrane Database Syst Rev 2006; (1): CD003263.
Lotti T, Gori A, Zanieri F, Colucci R, Moretti S. Vitiligo: new and emerging treatments. Dermatol Ther 2008; 21: 110-7.
Njoo MD, Westerhof W. Therapeutic guidelines for vitiligo. In: Lotti T, Hercogova J, editors. Vitiligo: Problems and Solutions. New York, NY: Marcel Dekker; 2004: 235-52.
Cicarma E, Mork C, Porojnicu AC, Juzeniene A, Dahlback A, Moan J. Influence of narrowband UVB phototherapy on vitamin D and folate status. Exp Dermatol 2010; 19: 67-72.
Jalel A, Soumaya GS, Hamdaoui MH. Vitiligo treatment with vitamins, minerals and polyphenol supplementation. Indian J Dermatol 2009; 54: 357-60.
Oikawa A, Nakayasu M. Stimulation of melanogenesis in cultured melanoma cells by calciferols. FEBS Lett 1974; 42: 32–5.
AlGhamdi K, Kumar A, Moussa N. The role of vitamin D in melanogenesis with an emphasis on vitiligo. Indian J Dermatol Venereol Leprol 2013; 79: 750-8.
Karagün E, Ergin C, Baysak S, Erden G, Aktaş H and Ekiz O. The role of serum vitamin D levels in vitiligo. Postepy Dermatol Alergol 2016; 33(4): 300–302.
Awad SA, Morsy H, Abdel-Aal AM, Ibrahim AK. Effect of narrowband ultraviolet B phototherapy on serum vitamin D levels in patients with vitiligo. J Egypt Women Dermatol Soc 2016; 13: 37–42.
Saleh HM, Abdel Fattah NS, Hamza HT. Evaluation of serum 25-hydroxyvitamin D levels in vitiligo patients with and without autoimmune diseases. Photodermatol Photoimmunol Photomed 2013; 29: 34–40.
Vähävihu K, Ylianttila L, Kautiainen H, Viljakainen H, Lamberg-Allardt C. Narrowband ultraviolet B course improves vitamin D balance in women in winter. Br J Dermatol 2010; 162: 848-53.
Sehrawat M, Arora TC, Chauhan A, Kar HK, Poonia A. Correlation of vitamin D levels with pigmentation in vitiligo patients treated with NBUVB Therapy. ISRN Dermatology 2014; Article ID 493213, 6 pages.
El-Hanbuli HM, Dawoud NM, Mahmoud RH. Narrow-band UVB effects on cutaneous vitamin D receptor expression and serum 25-hydroxyvitamin D in generalized vitiligo. Photodermatol Photoimmunol Photomed. 2018; 34(3): 175-183.
Birlea SA, Costin GE, Norris DA. Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation. Curr Drug Targets 2008; 9: 345-59.
Birlea SA, Costin GE. New insights on therapy with vitamin D analogs targeting the intracellular pathways that control repigmentation in human vitiligo. Med Res Rev 2009; 29: 514-46.
Ibrahim H1, El Taieb M2, El Gamel Z3, El Saied AR4. Effect of narrow-band ultraviolet B on the serum of 25-hydroxyvitamin D in vitiligo patients. J Cosmet Dermatol 2018; 17(5): 911-916.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
